0 items USD 0.00Search
Your search for "delveinsight post menopausal osteoporosis epidemiology forecast 2023" gave back 215604 results.
Market Analysis and Insights: Global Bronchopulmonary Dysplasia (BPD) Epidemiology Market The global Bronchopulmonary Dysplasia (BPD) Epidemiology...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Market Analysis and Insights: Global Homozygous Familial Hypercholesterolemia Epidemiology Market The global Homozygous Familial Hypercholesterolemia...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
The “Homozygous Familial Hypercholesterolemia Epidemiology Industry Forecast” looks at past sales and reviews total world Homozygous Familial...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The “Bronchopulmonary Dysplasia (BPD) Epidemiology Industry Forecast” looks at past sales and reviews total world Bronchopulmonary Dysplasia (BPD)...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Highlights The global Homozygous Familial Hypercholesterolemia Epidemiology market was valued at US$ million in 2022 and is anticipated to reach US$...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Highlights The global Bronchopulmonary Dysplasia (BPD) Epidemiology market was valued at US$ million in 2022 and is anticipated to reach US$ million...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Women have special nutrition needs due to hormonal changes which occur with the pregnancy, menstruation, menopause and lactation which alter the...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Estrogen Receptor - Pipeline Review, H2 2019 Summary Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
Estrogen Receptor (ER Alpha or Estradiol Receptor or Nuclear Receptor Subfamily 3 Group A Member 1 or NR3A1 or ESR1) - Pipeline Review, H2 2018...
Catalog:
Global Markets Direct
September 2018
Price: USD 3,500.00
Ibandronate is prescription medication used for treating osteoporosis in women after menopause. The “Ibandronate Industry Forecast” looks at past...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Lipid-regulating drugs are used to treat dyslipidemias, cardiovascular problems, osteoporosis, and post-menopause complications. The global Lipid-...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Ibandronate is prescription medication used for treating osteoporosis in women after menopause. Highlights The global Ibandronate market was valued...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Lipid-regulating drugs are used to treat dyslipidemias, cardiovascular problems, osteoporosis, and post-menopause complications. The “Lipid-...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Raloxifene, primarily used to prevent and treat osteoporosis in postmenopausal women, has been shown to significantly reduce the incidence of...
Catalog:
LPI
March 2023
Price: USD 3,660.00
It's used to treat osteoporosis (weak and brittle bones) caused by menopause or long-term steroid use. Publisher' newest research report,...
Catalog:
LPI
January 2023
Price: USD 3,660.00
